The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Van Wilgenburg, Bonnie ^a   Moore, Michael D ^a   James, William S ^a   Cowley, Sally A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PROTEIN KINASE LCK;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DETERGENT RESISTANT MEMBRANE; DNA MODIFICATION; EMBRYO; ENDOCYTOSIS; GENE SILENCING; GENETIC MANIPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIPID RAFT; MACROPHAGE; MEMBRANE FUSION; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; VIRUS DNA CELL DNA INTERACTION; VIRUS ENTRY;

ANIMALS; ANTIGENS, CD4; CELL LINE; ENDOCYTOSIS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENE ORDER; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MACROPHAGES; MEMBRANE MICRODOMAINS; MICE; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84899884558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086071     Document Type: Article

References (106)

1. Harbison MA, Gillis JM, Pinkston P, Byrn RA, Rose RM, et al. (1990) Effects of recombinant soluble CD4 (rCD4) on HIV-1 infection of monocyte/ macrophages. The Journal of infectious diseases 161: 1-6. (Pubitemid 20021847)
2. Collman R, Godfrey B, Cutilli J, Rhodes A, Hassan NF, et al. (1990) Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. Journal of Virology 64: 4468-4476. (Pubitemid 20279860)
3. Jordan CA, Watkins BA, Kufta C, Dubois-Dalcq M (1991) Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. Journal of Virology 65: 736-742.
4. Ho WZ, Lioy J, Song L, Cutilli JR, Polin RA, et al. (1992) Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. Journal of Virology 66: 573-579.
5. Collin M, Herbein G, Montaner L, Gordon S (1993) PCR analysis of HIV1 infection of macrophages: virus entry is CD4-dependent. Research in virology 144: 13-19. (Pubitemid 23068328)
6. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, et al. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763-767. (Pubitemid 15195924)
7. Cole JA, McCarthy SA, Rees MA, Sharrow SO, Singer A (1989) Cell surface comodulation of CD4 and T cell receptor by anti-CD4 monoclonal antibody. J Immunol 143: 397-402. (Pubitemid 19191528)
8. Karsten V, Gordon S, Kirn A, Herbein G (1996) HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha. Immunology 88: 55-60. (Pubitemid 26166376)
9. Garofalo T, Sorice M, Misasi R, Cinque B, Giammatteo M, et al. (1998) A novel mechanism of CD4 down-modulation induced by monosialoganglioside GM3. Involvement of serine phosphorylation and protein kinase C delta translocation. J Biol Chem 273: 35153-35160. (Pubitemid 29028219)
10. Pitcher C, Höning S, Fingerhut A, Bowers K, Marsh M (1999) Cluster of Differentiation Antigen 4 (CD4) Endocytosis and Adaptor Complex Binding Require Activation of the CD4 Endocytosis Signal by Serine Phosphorylation. Molecular Biology of the Cell 10: 677-691. (Pubitemid 29144631)
11. Raposo RA, Trudgian DC, Thomas B, van Wilgenburg B, Cowley SA, et al. (2011) Protein kinase C and NF-kappa B-dependent CD4 downregulation in macrophages induced by T cell-derived soluble factors: consequences for HIV-1 infection. Journal of Immunology 187: 748-759.
12. Perlmutter RM, Marth JD, Lewis DB, Peet R, Ziegler SF, et al. (1988) Structure and expression of lck transcripts in human lymphoid cells. Journal of Cellular Biochemistry 38: 117-126. (Pubitemid 18262927)
13. Pelchen-Matthews A, da Silva RP, Bijlmakers MJ, Signoret N, Gordon S, et al. (1998) Lack of p56lck expression correlates with CD4 endocytosis in primary lymphoid and myeloid cells. Eur J Immunol 28: 3639-3647. (Pubitemid 28510774)
14. Pelchen-Matthews A, Armes JE, Griffiths G, Marsh M (1991) Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. J Exp Med 173: 575-587.
15. Marechal V, Prevost MC, Petit C, Perret E, Heard JM, et al. (2001) Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. Journal of Virology 75: 11166-11177. (Pubitemid 33031583)
16. Gobeil LA, Lodge R, Tremblay MJ (2013) Macropinocytosis-like HIV-1 internalization in macrophages is CCR5 dependent and leads to efficient but delayed degradation in endosomal compartments. Journal of Virology 87: 735-745.
17. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, et al. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657.
18. Carter GC, Bernstone L, Sangani D, Bee JW, Harder T, et al. (2009) HIV entry in macrophages is dependent on intact lipid rafts. Virology 386: 192-202.
19. Carter GC, Bernstone L, Baskaran D, James W (2011) HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 409: 234-250.
20. Meylan PR, Spina CA, Richman DD, Kornbluth RS (1993) In vitro differentiation of monocytoid THP-1 cells affects their permissiveness for HIV strains: a model system for studying the cellular basis of HIV differential tropism. Virology 193: 256-267.
21. Cassol E, Alfano M, Biswas P, Poli G (2006) Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol 80: 1018-1030. (Pubitemid 44646308)
22. Cowley SA, Karlsson KR, van Wilgenburg B, Carter G, Browne C, et al. (2012) Macrophages from human Pluripotent Stem Cells. In: Takahashi R HK, editor. Macrophages: Life Cycle, Functions and Diseases. NY: Nova Science Publishers.
23. Karlsson KR, Cowley S, Martinez FO, Shaw M, Minger SL, et al. (2008) Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3. Exp Hematol 36: 1167-1175.
24. van Wilgenburg B, Browne C, Vowles J, Cowley SA (2013) Efficient, Long Term Production of Monocyte-Derived Macrophages from Human Pluripotent Stem Cells under Partly-Defined and Fully-Defined Conditions. PLoS ONE 8: e71098.
25. Bennett S, Breit SN (1994) Variables in the isolation and culture of human monocytes that are of particular relevance to studies of HIV. J Leukoc Biol 56: 236-240. (Pubitemid 24295789)
26. Honda Y, Rogers L, Nakata K, Zhao BY, Pine R, et al. (1998) Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/ EBP) beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 188: 1255-1265. (Pubitemid 28478014)
27. Zybarth G, Reiling N, Schmidtmayerova H, Sherry B, Bukrinsky M (1999) Activation-induced resistance of human macrophages to HIV-1 infection in vitro. J Immunol 162: 400-406. (Pubitemid 29018947)
28. Eisert V, Kreutz M, Becker K, Konigs C, Alex U, et al. (2001) Analysis of cellular factors influencing the replication of human immunodeficiency virus type I in human macrophages derived from blood of different healthy donors. Virology 286: 31-44. (Pubitemid 32675463)
29. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nature reviews Immunology 5: 953-964. (Pubitemid 41746764)
30. Bol SM, van Remmerden Y, Sietzema JG, Kootstra NA, Schuitemaker H, et al. (2009) Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages. Virology 390: 205-211.
31. Kaushik R, Zhu X, Stranska R, Wu Y, Stevenson M (2009) A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host & Microbe 6: 68-80.
32. Laguette N, Bregnard C, Bouchet J, Benmerah A, Benichou S, et al. (2009) Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase. Journal of Virology 83: 7117-7128.
33. Simpson SC, Bolen JB, Veillette A (1989) CD4 and p56lck can stably associate when co-expressed in NIH3T3 cells. Oncogene 4: 1141-1143. (Pubitemid 19211731)
34. Pelchen-Matthews A, Boulet I, Littman DR, Fagard R, Marsh M (1992) The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits. J Cell Biol 117: 279-290.
35. Pelchen-Matthews A, Clapham P, Marsh M (1995) Role of CD4 endocytosis in human immunodeficiency virus infection. Journal of Virology 69: 8164-8168.
36. Gray L, Sterjovski J, Churchill M, Ellery P, Nasr N, et al. (2005) Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome. Virology 337: 384-398. (Pubitemid 40799005)
37. Arrildt K, Joseph S, Schnell G, Spudich S, Price R, et al. (2012) HIV-1 Infection of Macrophages Is Restricted by Host Cell CD4 Density, Which Is Variable. The Conference on Retroviruses and Opportunistic Infections (CROI). Seattle.
38. Dimitrov DS, Norwood D, Stantchev TS, Feng Y, Xiao X, et al. (1999) A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages. Virology 259: 1-6. (Pubitemid 29391750)
39. Rodgers W, Crise B, Rose JK (1994) Signals determining protein tyrosine kinase and glycosyl-phosphatidylinositol-anchored protein targeting to a glycolipid-enriched membrane fraction. Molecular and Cellular Biology 14: 5384-5391.
40. Kwong J, Lublin DM (1995) Amino-terminal palmitate or polybasic domain can provide required second signal to myristate for membrane binding of p56lck. Biochemical and Biophysical Research Communications 207: 868-876.
41. Filipp D, Zhang J, Leung BL, Shaw A, Levin SD, et al. (2003) Regulation of Fyn through translocation of activated Lck into lipid rafts. The Journal of Experimental Medicine 197: 1221-1227. (Pubitemid 36570078)
42. Nyakeriga AM, Fichtenbaum CJ, Goebel J, Nicolaou SA, Conforti L, et al. (2009) Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immunodeficiency virus type 1 infection. Journal of Virology 83: 1193-1200.
43. Gombos I, Bacso Z, Detre C, Nagy H, Goda K, et al. (2004) Cholesterol sensitivity of detergent resistance: a rapid flow cytometric test for detecting constitutive or induced raft association of membrane proteins. Cytometry Part A: the journal of the International Society for Analytical Cytology 61: 117-126.
44. Gombos I, Detre C, Vamosi G, Matko J (2004) Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation. Immunology letters 92: 117-124. (Pubitemid 38470058)
45. Bacso Z, Nagy H, Goda K, Bene L, Fenyvesi F, et al. (2004) Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein. Cytometry A 61: 105-116. (Pubitemid 39362285)
46. Calzolari A, Raggi C, Deaglio S, Sposi NM, Stafsnes M, et al. (2006) TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. Journal of Cell Science 119: 4486-4498. (Pubitemid 44830648)
47. Wolf Z, Orso E, Werner T, Boettcher A, Schmitz G (2006) A flow cytometric screening test for detergent-resistant surface antigens in monocytes. Cytometry A 69: 192-195.
48. Wolf Z, Orso E, Werner T, Klunemann HH, Schmitz G (2007) Monocyte cholesterol homeostasis correlates with the presence of detergent resistant membrane microdomains. Cytometry A 71: 486-494. (Pubitemid 47036039)
49. Kiss E, Nagy P, Balogh A, Szollosi J, Matko J (2008) Cytometry of raft and caveola membrane microdomains: from flow and imaging techniques to high throughput screening assays. Cytometry Part A: the journal of the International Society for Analytical Cytology 73: 599-614.
50. Cavrois M, De Noronha C, Greene WC (2002) A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nature biotechnology 20: 1151-1154. (Pubitemid 35285446)
51. Aiken C (1997) Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J Virol 71: 5871-5877.
52. Hussey RE, Richardson NE, Kowalski M, Brown NR, Chang HC, et al. (1988) A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature 331: 78-81. (Pubitemid 18053421)
53. Lee SK, Dykxhoorn DM, Kumar P, Ranjbar S, Song E, et al. (2005) Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106: 818-826. (Pubitemid 41076420)
54. Bannert N, Schenten D, Craig S, Sodroski J (2000) The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses. Journal of Virology 74: 10984-10993. (Pubitemid 32223963)
55. Peters PJ, Bhattacharya J, Hibbitts S, Dittmar MT, Simmons G, et al. (2004) Biological Analysis of Human Immunodeficiency Virus Type 1 R5 Envelopes Amplified from Brain and Lymph Node Tissues of AIDS Patients with Neuropathology Reveals Two Distinct Tropism Phenotypes and Identifies Envelopes in the Brain That Confer an Enhanced Tropism and Fusigenicity for Macrophages. Journal of Virology 78: 6915-6926. (Pubitemid 38781530)
56. Crise B, Rose JK (1992) Identification of palmitoylation sites on CD4, the human immunodeficiency virus receptor. The Journal of Biological Chemistry 267: 13593-13597.
57. Popik W, Alce TM (2004) CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4. J Biol Chem 279: 704-712. (Pubitemid 38044875)
58. Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, et al. (2003) HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. J Biol Chem 278: 3153-3161. (Pubitemid 36805610)
59. Fragoso R, Ren D, Zhang X, Su MW, Burakoff SJ, et al. (2003) Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. Journal of Immunology 170: 913-921. (Pubitemid 36070545)
60. Balamuth F, Brogdon JL, Bottomly K (2004) CD4 raft association and signaling regulate molecular clustering at the immunological synapse site. Journal of Immunology 172: 5887-5892. (Pubitemid 38621186)
61. Peterson A, Seed B (1988) Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54: 65-72.
62. Jameson BA, Rao PE, Kong LI, Hahn BH, Shaw GM, et al. (1988) Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science 240: 1335-1339.
63. Arthos J, Deen KC, Chaikin MA, Fornwald JA, Sathe G, et al. (1989) Identification of the residues in human CD4 critical for the binding of HIV. Cell 57: 469-481. (Pubitemid 19126280)
64. Brodsky MH, Warton M, Myers RM, Littman DR (1990) Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. Journal of Immunology 144: 3078-3086. (Pubitemid 20149483)
65. Brown MH, Barclay AN (1994) Expression of immunoglobulin and scavenger receptor superfamily domains as chimeric proteins with domains 3 and 4 of CD4 for ligand analysis. Protein Engineering 7: 515-521. (Pubitemid 24106804)
66. Scherer WF, Syverton JT, Gey GO (1953) Studies on the Propagation Invitro of Poliomyelitis Viruses 4. Viral Multiplication in a Stable Strain of Human Malignant Epithelial Cells (Strain Hela) Derived from an Epidermoid Carcinoma of the Cervix. Journal of Experimental Medicine 97: 695-&.
67. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. Journal of Virology 72: 2855-2864. (Pubitemid 28175522)
68. Stolp B, Fackler OT (2011) How HIV Takes Advantage of the Cytoskeleton in Entry and Replication. Viruses 3: 293-311.
69. Mooren OL, Galletta BJ, Cooper JA (2012) Roles for actin assembly in endocytosis. Annual Review of Biochemistry 81: 661-686.
70. Gobeil LA, Lodge R, Tremblay MJ (2012) Differential HIV-1 endocytosis and susceptibility to virus infection in human macrophages correlate with the cell activation status. Journal of Virology.
71. Spear M, Guo J, Wu Y (2012) The trinity of the cortical actin in the initiation of HIV-1 infection. Retrovirology 9: 45.
72. Kadiu I, Gendelman HE (2011) Human immunodeficiency virus type 1 endocytic trafficking through macrophage bridging conduits facilitates spread of infection. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology 6: 658-675.
73. Permanyer M, Ballana E, Este JA (2010) Endocytosis of HIV: anything goes. Trends in Microbiology 18: 543-551.
74. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nature reviews Molecular cell biology 1: 31-39.
75. Harder T, Scheiffele P, Verkade P, Simons K (1998) Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 141: 929-942. (Pubitemid 28243961)
76. Munro S (2003) Lipid rafts: elusive or illusive? Cell 115: 377-388.
77. Henderson RM, Edwardson JM, Geisse NA, Saslowsky DE (2004) Lipid rafts: feeling is believing. News in physiological sciences: an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society 19: 39-43.
78. Ostrom RS, Liu X (2007) Detergent and detergent-free methods to define lipid rafts and caveolae. Methods in Molecular Biology 400: 459-468. (Pubitemid 350183707)
79. Yang C, Spies CP, Compans RW (1995) The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. Proceedings of the National Academy of Sciences of the United States of America 92: 9871-9875.
80. Rousso I, Mixon MB, Chen BK, Kim PS (2000) Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. Proceedings of the National Academy of Sciences of the United States of America 97: 13523-13525.
81. Mahfoud R, Garmy N, Maresca M, Yahi N, Puigserver A, et al. (2002) Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J Biol Chem 277: 11292-11296. (Pubitemid 34952893)
82. Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, et al. (1991) Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253: 320-323. (Pubitemid 21917158)
83. Puri A, Hug P, Jernigan K, Barchi J, Kim HY, et al. (1998) The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein. Proceedings of the National Academy of Sciences of the United States of America 95: 14435-14440. (Pubitemid 28549385)
84. Hammache D, Pieroni G, Yahi N, Delezay O, Koch N, et al. (1998) Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J Biol Chem 273: 7967-7971. (Pubitemid 28168845)
85. Hammache D, Yahi N, Maresca M, Pieroni G, Fantini J (1999) Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). Journal of Virology 73: 5244-5248. (Pubitemid 29246795)
86. Van Mau N, Misse D, Le Grimellec C, Divita G, Heitz F, et al. (2000) The SU glycoprotein 120 from HIV-1 penetrates into lipid monolayers mimicking plasma membranes. J Membr Biol 177: 251-257. (Pubitemid 32268861)
87. Hug P, Lin H-MJ, Korte T, Xiao X, Dimitrov DS, et al. (2000) Glycosphingolipids Promote Entry of a Broad Range of Human Immunodeficiency Virus Type 1 Isolates into Cell Lines Expressing CD4, CXCR4, and/ or CCR5. Journal of Virology 74: 6377-6385. (Pubitemid 30429803)
88. Manes S, del Real G, Lacalle RA, Lucas P, Gomez-Mouton C, et al. (2000) Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO reports 1: 190-196.
89. Rawat SS, Johnson BT, Puri A (2005) Sphingolipids: modulators of HIV-1 infection and pathogenesis. Biosci Rep 25: 329-343. (Pubitemid 41712662)
90. Fuki IV, Meyer ME, Williams KJ (2000) Transmembrane and cytoplasmic domains of syndecan mediate a multi-step endocytic pathway involving detergent-insoluble membrane rafts. Biochemical Journal 351 Pt 3: 607-612.
91. Saphire AC, Bobardt MD, Zhang Z, David G, Gallay PA (2001) Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. Journal of Virology 75: 9187-9200. (Pubitemid 32851923)
92. Tkachenko E, Simons M (2002) Clustering induces redistribution of syndecan-4 core protein into raft membrane domains. J Biol Chem 277: 19946-19951. (Pubitemid 34967516)
93. Wilsie LC, Gonzales AM, Orlando RA (2006) Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptorrelated protein (LRP)-independent, non-clathrin-mediated pathway. Lipids Health Dis 5: 23.
94. Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, et al. (2004) Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350: 1353-1356. (Pubitemid 38375373)
95. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnology 15: 871-875.
96. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, et al. (2002) High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13: 803-813. (Pubitemid 34493974)
97. García-Expósito L, Barroso-González J, Puigdomènech I, Machado J-D, Blanco J, et al. (2011) HIV-1 requires Arf6-mediated membrane dynamics to efficiently enter and infect T lymphocytes. Molecular Biology of the Cell 22: 1148-1166.
98. Kamiya D, Banno S, Sasai N, Ohgushi M, Inomata H, et al. (2011) Intrinsic transition of embryonic stem-cell differentiation into neural progenitors. Nature 470: 503-509.
99. Thanakiatkrai P, Welch L (2012) Using the Taguchi method for rapid quantitative PCR optimization with SYBR Green I. Int J Legal Med 126: 161-165.
100. Zhou L, Sokolskaja E, Jolly C, James W, Cowley SA, et al. (2011) Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration. PLoS Pathogens 7: e1002194.
101. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
102. Connor RI, Chen BK, Choe S, Landau NR (1995) Vpr Is Required for Efficient Replication of Human-Immunodeficiency-Virus Type-1 in Mononuclear Phagocytes. Virology 206: 935-944.
103. He Y, Chen H, Quon MJ, Reitman M (1995) The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein alpha. J Biol Chem 270: 28887-28891.
104. Matlin KS, Reggio H, Helenius A, Simons K (1982) Pathway of vesicular stomatitis virus entry leading to infection. Journal of Molecular Biology 156: 609-631. (Pubitemid 12053587)
105. Yamada S, Ohnishi S (1986) Vesicular stomatitis virus binds and fuses with phospholipid domain in target cell membranes. Biochemistry 25: 3703-3708. (Pubitemid 16067155)
106. Gartner S, Markovits P, Markovitz DM, Betts RF, Popovic M (1986) Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA: the journal of the American Medical Association 256: 2365-2371.